Supernus Pharmaceuticals, Inc. · 4 months ago
Sales Analyst II
Rockville, MD
Full-time
Onsite
Entry, Mid Level
$65K/yr - $78K/yr
2+ years expSupernus Pharmaceuticals is an award-winning biopharmaceutical company with over 30 years of experience in developing products for CNS diseases. The Sales Analyst II will support the field sales organization through data analysis and reporting, while also assisting Marketing Operations.
BiotechnologyHealth CarePharmaceutical
No H1B
Responsibilities
Responsible for supporting team in the timely and accurate delivery of all sales reports, schedules, tables and lists
Conduct ad hoc analysis for the Commercial team using BI tools, CRM, Excel and PowerPoint
Support Incentive Compensation functions with delivery of aligned sales data
Work with Prescription data to perform targeting and segmentation analysis
Assist with developing territory alignments; maintain ongoing territory alignment adjustments using mapping software
Assist sales representatives with data, process, and system questions as needed; perform territory/account research
Participates on multi-functional project teams as assigned
Other responsibilities and projects as assigned
Qualification
Required
Bachelor's degree required and a minimum of 2+ years of related work experience
Working knowledge and experience with Microsoft Office, Excellent Excel skills required (pivots, macros, v/h/x lookups, etc.)
Strong analytical and problem-solving skills
Ability to handle highly confidential information
Ability to recognize and adapt to change and ability to multi-task
Demonstrated initiative and willingness to overcome challenges
Ability to effectively communicate the findings associated with data analysis or team member questions
Authorized to legally work in the United States without visa sponsorship
Preferred
Experience with Salesforce.com/Veeva or a similar CRM system a plus
Experience with BI tools a plus
Experience Pharmaceutical /biotechnology industry preferred
Benefits
Opportunity to participate in employee stock purchase programs
Performance-based bonus programs
Company
Supernus Pharmaceuticals, Inc.
We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$689.5MKey Investors
UBSNew Enterprise Associates
2023-02-14Post Ipo Debt· $150M
2018-03-13Post Ipo Debt· $350M
2013-04-24Post Ipo Debt· $90M
Leadership Team
J
Jack A. Khattar
President & CEO
F
Frank Mottola
Chief Technical Operations Officer
Recent News
2025-12-08
Company data provided by crunchbase